Tad Pharma Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Tad Pharma Gmbh

Patent Number:
Title:
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
Applicant:
Opposition Date:
Aug 30, 2023
Patent Number:
Title:
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
Applicant:
Opposition Date:
Mar 8, 2021

Competitors of Tad Pharma Gmbh

AMGEN INC.

AMGEN, INC

Want to track Tad Pharma Gmbh?

Feel free to send us a message here and we will get back to you